Product Image

Omega 3 Fish Oil

Dr. Tobias
4.8
★ ★ ★ ★ ★
(606 ratings)
EPA (Eicosapentaenoic Acid) 800 mg
Fish Oil 2000 mg
DHA 600 mg
Product Image
Score81
A concentrated EPA-and-DHA serving is clearly disclosed, but missing form and testing details limit confidence in oil quality.
How scoring works
Quantity:180 Softgel(s) • (90 servings)
Goals:
Heart Health
Cardiovascular Support
Anti-Inflammatory Support
Mental Focus

Score 81

A concentrated EPA-and-DHA serving is clearly disclosed, but missing form and testing details limit confidence in oil quality.
How scoring works
$43.02($0.47 per serving)
iHerb
$ 43.02
Report prices

Analysis

The formula supplies 800 mg EPA and 600 mg DHA per serving, giving a substantial omega-3 dose. Both key omega-3s are quantified, so the active amount is easy to assess.

The concentrated serving fits adults seeking meaningful omega-3 intake for heart health and cardiovascular support. The amount of active omega-3 provided per serving also compares favorably with the product cost.

The label does not identify the omega-3 molecular form or provide independent purity and oxidation test results, so important quality details remain uncertain. The softgel(s) format may be convenient for routine use, but the disclosed facts do not establish freshness or contaminant control.

Who is it for
  • Adults seeking a concentrated daily fish-oil serving
  • People focused on cardiovascular or inflammatory support
Best for
  • Heart Health
  • Cardiovascular Support
  • Anti-Inflammatory Support

Pros

  • EPA and DHA are listed separately at 800 mg and 600 mg per serving
  • Concentrated active omega-3 amount per serving
  • Serving count supports a practical daily routine

Cons

  • Omega-3 molecular form is not identified
  • Independent purity and oxidation testing is not provided
  • Fish source or processing details are limited

Warnings

  • Avoid if you have a fish allergy because the active oil is fish-derived.
  • The 1400 mg combined EPA, DHA serving may add to bleeding risk with anticoagulant or antiplatelet medicines; discuss this dose with the prescribing clinician.
  • Fish oil can cause burping or stomach upset; taking it with a meal may improve tolerance.

Nutrient quality

84 Highest impact

A highly concentrated EPA-and-DHA dose provides strong depth for heart and inflammatory support. Missing oxidation protection, sourcing, molecular-form, and testing details are important quality gaps.

.

Ingredient transparency

79 High impact

Active amounts are individually disclosed, and no proprietary blend hides the supplied doses. Complete use directions, excipients, and some source or quality details remain unavailable.

.

Customer satisfaction

69 High impact

Supplied aggregate data indicate very strong satisfaction with a solid response base. Specific comments are absent, so recurring complaints and purpose-specific experiences cannot be verified.

.

Value for money

89 Highest impact

High EPA and DHA yield provides strong practical value. Missing stability and quality-control details prevent a stronger assurance case.

.
Report analysis

Goals

Heart Health
Heart Health
Impact
Highest effect
A+ Goal FitA- Strength of SupportB+ CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 800 mg

EPA and DHA directly support lipid management, vascular function, and inflammatory balance. The formula is focused on omega fatty acids rather than multiple heart pathways, but that focus is clinically meaningful.

The combined EPA and DHA amount is substantial and fully disclosed. The molecular form, oxidation controls, and contaminant testing are not stated, which limits quality assurance.

Study evidence
Cardiovascular Support
Cardiovascular Support
Impact
Highest effect
A Goal FitA- Strength of SupportC+ CoverageA+ Formula Quality
Fish Oil · 2000 mg

The clearly disclosed EPA and DHA amounts provide strong support for triglyceride management, inflammatory balance, and endothelial function. The formula directly addresses a central cardiovascular nutrition pathway.

The concentrated fish-oil serving is substantial, but molecular form, purification, oxidation control, and sustainability details are not provided. Fish oil at this amount may increase bruising or bleeding tendency with anticoagulant or antiplatelet medicines.

Study evidence
Fish Oil Supportive 185 studies
Anti-Inflammatory Support
Anti-Inflammatory Support
Impact
Highest effect
A+ Goal FitB Strength of SupportC+ CoverageA+ Formula Quality
Fish Oil · 2000 mg

The concentrated EPA and DHA serving strongly aligns with inflammation support by supplying precursors for specialized pro-resolving mediators. The active amount provides excellent depth for a focused single-pathway product.

EPA and DHA quantities are clearly listed, but the oil molecular form, fish species, purification, independent testing, and antioxidant protection are not disclosed. Those omissions limit confidence in freshness and manufacturing quality despite the strong dose.

Study evidence
Fish Oil Supportive 68 studies
Mental Focus
Mental Focus
Impact
High effect
D+ Goal FitB- Strength of SupportC- CoverageA+ Formula Quality

EPA and DHA provide substantial foundational support for brain structure and inflammatory balance. Their effect on day-to-day focus is indirect and is unlikely to resemble an acute nootropic or stimulant response.

The fatty-acid amounts are clearly disclosed and concentrated into a simple two-softgel serving. Molecular form, oxidation protection, and contaminant testing are not identified, leaving meaningful quality uncertainty.

Study evidence

Ingredients

IngredientAmount per serving
Calories
20 Calorie(s)
Calories from Fat
20 Calorie(s)
Total Fat
2 Gram(s)
Fish Oil
2000 mg
Eicosapentaenoic Acid
800 mg
Docosahexaenoic Acid
600 mg
Adults 18–50
Report overview
EPA (Eicosapentaenoic Acid) · 800 mg OverallScore67
D Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyA+ Value

The EPA concentration is solid, but the molecular form and oxidation protection are not disclosed. The dose reaches the high end for EPA-focused support, although the EPA-to-DHA balance falls short of the strongest EPA-centric ratio. Cost efficiency is excellent, while the lack of stated contaminant testing leaves a meaningful transparency gap.

View ingredientView products
Fish Oil · 2000 mg OverallScore54
F Active Ingredient Quality & BioavailabilityB Dose, Safety & Label TransparencyA+ Value

The EPA and DHA dose is substantial and highly concentrated relative to the total oil. Its cost per active amount is excellent. Unspecified molecular form, fish species, purification, independent testing, and antioxidant protection leave important quality gaps.

View ingredientView products
DHA · 600 mg OverallScore46
F Active Ingredient Quality & BioavailabilityD Dose, Safety & Label TransparencyB+ Value
The DHA serving is potent and the combined EPA and DHA make up a substantial share of the fish oil. The chemical form, fish species, antioxidant protection, and contaminant testing are not disclosed. Cost per gram of DHA is favorable, but the missing quality details limit confidence in long-term oil stability and sourcing.
View ingredientView products
Loading alternative details
87 Performance

Omega-3

Solgar
<p>A more concentrated serving provides 1,008 mg EPA and 756 mg DHA, giving greater omega-3 depth than the original's 800 mg EPA and 600 mg DHA. Mixed tocopherols aid oxidation control, but molecular form, fish source, purification method, and independent testing remain unclear.</p>
85 Performance

Omega-3 Triglyceride Fish Oil 1100 mg

NATURELO Premium Supplements
<p>A molecularly distilled triglyceride fish oil with 729 mg EPA and 275 mg DHA provides more specific form and processing detail than the original. Molecular distillation adds some purity assurance, while missing independent testing, fish species, and antioxidant protection leave smaller quality gaps.</p>
83 Performance

Super Omega-3

Life Extension
<p>A clearly quantified serving of 700 mg EPA and 500 mg DHA offers a more focused EPA-and-DHA profile than the original. The large package provides strong active value, though the four-softgel serving is less convenient and oil-quality documentation remains incomplete.</p>
86 Budget

Omega-3 Triglyceride Fish Oil 1100 mg

NATURELO Premium Supplements
<p>A lower recurring cost provides 729 mg EPA and 275 mg DHA, compared with the original's 800 mg EPA and 600 mg DHA. Molecular distillation adds some purity assurance, while missing independent testing, fish species, and antioxidant protection leave smaller quality gaps.</p>
86 Budget

Purified & Clear Omega 3 Fish Oil 1000 mg

Doctor's Best
<p>A lower recurring cost provides 800 mg EPA and 400 mg DHA, compared with the original's 800 mg EPA and 600 mg DHA. The ethyl-ester form is less readily absorbed than triglyceride oil, and oxidation protection plus independent purity testing are not supplied.</p>
84 Budget

Mega EPA/DHA

Life Extension
<p>A lower recurring cost provides 720 mg EPA and 480 mg DHA, compared with the original's 800 mg EPA and 600 mg DHA. The oil molecular form, fish species, purification, and independent testing remain undisclosed.</p>
84 Value

Fish Oil 1400 mg

Nature's Bounty
<p>A favorable balance of active dose and recurring cost provides 647 mg EPA and 253 mg DHA with better practical value than the original. The ethyl-ester form is less readily absorbed, while fish source, antioxidant protection, and independent purity testing are not stated.</p>
84 Value

Alaska Wild Fish Oil Mega Omega-3

21st Century
<p>A favorable balance of active dose and recurring cost provides 965 mg EPA and 385 mg DHA with better practical value than the original. Molecular form, antioxidant protection, fish species, and independent purity testing are not disclosed.</p>
83 Value

Super Omega-3

Life Extension
<p>A favorable balance of active dose and recurring cost provides 700 mg EPA and 500 mg DHA with better practical value than the original. The larger package improves active value, but fish species, molecular form, purification, and independent testing are not provided.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  2. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  3. Meta-analysis Comparing Combined Use of Eicosapentaenoic Acid and Statin to Statin Alone.
    Doshi R; Kumar A; Thakkar S; Shariff M; Adalja D; Doshi A; Taha M; Gupta R; Desai R; Shah J; Gullapalli N · The American journal of cardiology · 2020
    Meta-analysis27,415 participants5 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  4. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  5. Eicosapentaenoic Acid combined with optimal statin therapy improves endothelial dysfunction in patients with coronary artery disease.
    Toyama K; Nishioka T; Isshiki A; Ando T; Inoue Y; Kirimura M; Kamiyama T; Sasaki O; Ito H; Maruyama Y; Yoshimoto N · Cardiovascular drugs and therapy · 2014
    Randomized trial80 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  6. Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome.
    Satoh N; Shimatsu A; Kotani K; Himeno A; Majima T; Yamada K; Suganami T; Ogawa Y · Hypertension research : official journal of the Japanese Society of Hypertension · 2010
    Randomized trial92 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  7. The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review.
    Innes JK; Calder PC · International journal of molecular sciences · 2018
    Systematic review527 participants6 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  8. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids.
    Grimsgaard S; Bonaa KH; Hansen JB; Nordøy A · The American journal of clinical nutrition · 1997
    Randomized trial234 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  9. Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials.
    Hidayat K; Yang J; Zhang Z; Chen GC; Qin LQ; Eggersdorfer M; Zhang W · European journal of clinical nutrition · 2019
    Meta-analysis3,000 participants51 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  10. Long-Chain Polyunsaturated Fatty Acids Are Associated with Blood Pressure and Hypertension over 10-Years in Black South African Adults Undergoing Nutritional Transition.
    Zec MM; Schutte AE; Ricci C; Baumgartner J; Kruger IM; Smuts CM · Foods (Basel, Switzerland) · 2020
    Cohort study300 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  11. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsAnti-Inflammatory Support forFish Oil
  12. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsAnti-Inflammatory Support forFish Oil
  13. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsAnti-Inflammatory Support forFish Oil
  14. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsAnti-Inflammatory Support forFish Oil
  15. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledAnti-Inflammatory Support forFish Oil
  16. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  17. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  18. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  19. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  20. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  21. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  22. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  23. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  24. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  25. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  26. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)